Inactive Instrument

News EssilorLuxottica Other OTC

Stocks

ESLOF

FR0000121667

Medical Equipment, Supplies & Distribution

All News

01:40pm	Bernstein Sees EssilorLuxottica's Governance Issues as a 'Distraction'	MT
01:07pm	France Opens Probe on Alleged Use of Smart Glasses in Sexual Harassment Cases	MT
12:23pm	EssilorLuxottica : Bernstein reiterates its Neutral rating	ZD
10:09am	EssilorLuxottica : UBS reaffirms its Buy rating	ZD
09-17	Kepler Cheuvreux Downgrades EssilorLuxottica to Reduce, Cuts PT	MT
09-15	EssilorLuxottica : Gets a Buy rating from Jefferies	ZD
09-11	EssilorLuxottica Managers Reportedly Defend CEO as Founder's Son Escalates Criticism	MT
09-09	EssilorLuxottica board backs CEO Milleri after criticism from Del Vecchio heir	RE
09-09	EssilorLuxottica Board Maintains Confidence in Management, Strategy Following Exit of Founder's Son	MT
09-09	EssilorLuxottica : Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy	PU
09-09	EssilorLuxottica: EssilorLuxottica Board of Directors unanimously reaffirms confidence in the Company’s leadership and strategy	GL
09-07	EssilorLuxottica: Disclosure of transactions in own shares	GL
09-07	Based on fundamentals, there's nothing mysterious behind the slump in EssilorLuxottica's share price
09-07	So what is going on with EssilorLuxottica's governance -
09-07	EssilorLuxottica Reshuffles Executive Team After Departure of Founder's Son	MT
09-07	French and Benelux stocks-Factors to watch	RE
09-06	Son of EssilorLuxottica founder calls for new strategy for eyewear group	RE
08-31	EssilorLuxottica: Disclosure of transactions in own shares	GL
08-31	EssilorLuxottica announces the launch of a share buyback program	AQ
08-28	EssilorLuxottica Launches Buyback Program Potentially Valued at $918 Million	DJ
08-28	EssilorLuxottica Begins Buyback Program for Five Million Shares	MT
08-28	EssilorLuxottica announces the launch of a share buyback program	GL
08-27	EssilorLuxottica : 24-Month U.S. Clinical Trial Results Supporting FDA De Novo Market Authorization of Essilor Stellest Lenses* Published in JAMA Ophthalmology	PU
08-27	AlphaValue sticks with a Buy on EssilorLuxottica despite governance uncertainty
08-27	Delfin, Del Vecchio's exit reopens the succession file	AN